Safety and efficacy of adalimumab in patients with moderate to severe hidradenitis suppurativa: Results from first 12 weeks of PIONEER I, a phase 3, randomized, placebo-controlled trial

被引：0

作者：

Kimball, Alexa ^{[1
]}

Zouboulis, Christos ^{[2
,3
,4
,5
]}

Armstrong, April ^{[6
]}

Korman, Neil ^{[7
]}

Crowley, Jeffrey ^{[8
]}

Lynde, Charles ^{[9
]}

Belknap, Kimberly ^{[10
]}

Gu, Yihua ^{[10
]}

Williams, David ^{[10
]}

机构：

[1] Harvard Univ, Sch Med, Boston, MA USA

[2] Dept Dermatol, Dessau, Germany

[3] Dept Venereol, Dessau, Germany

[4] Dept Allergol, Dessau, Germany

[5] Dept Immunol, Dessau, Germany

[6] Univ Colorado, Denver, CO 80202 USA

[7] Univ Hosp Cleveland, Case Med Ctr, Cleveland, OH 44106 USA

[8] Bakersfield Dermatol, Bakersfield, CA USA

[9] Lynde Ctr Dermatol, Markham, ON, Canada

[10] AbbVie Inc, N Chicago, IL USA

来源：

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY | 2015年 / 72卷 / 05期

关键词：

D O I：

暂无

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

570

引用

页码：AB60 / AB60

页数：1

共 50 条

[1] Safety and efficacy of Adalimumab in patients with moderate to severe hidradenitis suppurativa: results from first 12 weeks of PIONEER I, a phase 3, randomized, placebo-controlled trial
Herra, L. Escudero
Kimball, A.
Zouboulis, C. C.
Armstrong, A. W.
Korman, N. J.
Crowley, J. J.
Lynde, C.
Belknap, K.
Gu, Y.
Williams, D. A.
[J]. AUSTRALASIAN JOURNAL OF DERMATOLOGY, 2015, 56 : 34 - 34
[2] Safety and Efficacy of Adalimumab in Patients with Moderate to Severe Hlidradenitis Suppurativa: Results from First 12 Weeks of PIONEER I, a Phase 3, Randomized, Placebo-Controlled Trial
Kimball, A.
Zouboulis, C. C.
Armstrong, A. W.
Korman, N.
Crowley, J. J.
Lynde, C.
Belknap, K.
Gu, Y.
Williams, D. A.
[J]. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2014, 134 : S36 - S36
[3] Efficacy and safety of adalimumab in patients with moderate to severe hidradenitis suppurativa: Results from PIONEER II, a phase 3, randomized, placebo-controlled trial
Jemec, Gregor
Gottlieb, Alice
Forman, Seth
Giamarellos-Bourboulis, Evangelos
Reguiai, Ziad
Gu, Yihua
Okun, Martin
[J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2015, 72 (05) : AB45 - AB45
[4] Efficacy and safety of Adalimumab in patients with moderate to severe hidradenitis suppurativa: results from PIONEER II, a phase 3 randomised placebo-controlled trial
Herra, L. Escudero
Jemec, G. B. E.
Gottlieb, A.
Forman, S.
Giamarellos-Bourboulis, E. J.
Reguiai, Z.
Gu, Y.
Okun, M. M.
[J]. AUSTRALASIAN JOURNAL OF DERMATOLOGY, 2015, 56 : 34 - 35
[5] Risk of flare in patients with hidradenitis suppurativa treated with adalimumab for 12 weeks during PIONEER I and PIONEER II: Two phase 3, randomized, placebo-controlled trials
Forman, Seth B.
Brooks, David M.
Gu, Yihua
Teixeira, Henrique D.
[J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2016, 74 (05) : AB71 - AB71
[6] Efficacy and safety of adalimumab in treatment of moderate to severe hidradenitis suppurativa: Results from the placebo-controlled portion of a phase II, randomized, double-blind study
Kimball, A.
Jemec, G.
Okun, M.
Gu, Y.
[J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2011, 64 (02) : AB155 - AB155
[7] Efficacy and safety of adalimumab in treatment of moderate to severe hidradenitis suppurativa: results from the placebo-controlled portion of a phase II, randomized, double-blind study
Kimball, A. B.
Jemec, G.
Gu, Y.
Okun, M.
[J]. BRITISH JOURNAL OF DERMATOLOGY, 2011, 165 : 6 - 6
[8] Adalimumab for nail psoriasis: Efficacy and safety from the first 26 weeks of a phase 3, randomized, placebo-controlled trial
Elewski, Boni E.
Okun, Martin M.
Papp, Kim
Baker, Christopher S.
Crowley, Jeffrey J.
Guillet, Gerard
Sundaram, Murali
Poulin, Yves
Gu, Yihua
Geng, Ziqian
Williams, David A.
Rich, Phoebe A.
[J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2018, 78 (01) : 90 - +
[9] Efficacy and Safety of Upadacitinib in Moderate-to-Severe Hidradenitis Suppurativa: A Phase 2, Randomized, Placebo-Controlled Study
Kimball, Alexa B.
Ackerman, Lindsay
Schlosser, Bethanee J.
Prajapati, Vimal H.
Fretzin, Scott
Takahashi, Hidetoshi
Zhan, Tianyu
Huang, Xiaohong
Camp, Heidi S.
[J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2023, 89 (03) : AB42 - AB42
[10] Adalimumab alleviates skin pain in patients with moderate-to-severe hidradenitis suppurativa: Secondary efficacy results from the PIONEER I and PIONEER II randomized controlled trials
Kimball, Alexandra B.
Sundaram, Murali
Shields, Alan L.
Hudgens, Stacie
Okun, Martin
Foley, Catherine
Ganguli, Arijit
[J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2018, 79 (06) : 1141 - 1143

← 1 2 3 4 5 →